Ipsen Strengthens U.S. Leadership with Michelle Werner’s Appointment as EVP and President of North America
Ipsen has named Michelle C. Werner Executive Vice President and President of North America, placing a seasoned biotech and pharmaceutical executive at the helm of one of its most important markets. In the role, Werner will join the company’s executive leadership team and report directly to CEO David Loew as Ipsen continues to expand its presence in oncology, rare disease, and neuroscience…










